| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |